Pricing
Prices are indicative MRP and may vary by pharmacy. Trend compares against the last recorded price.
All price changes →Save on this medicine
Same active ingredient — pay up to 27% less
These brands contain the same active ingredient (Ferric Maltol). Strength and form may differ — confirm substitution with your doctor or pharmacist before switching.
Indications & Uses
Tynifer is indicated for:
Dosage Reference
Reference Information Only
Dosages shown are general references from official sources. Always consult your doctor or pharmacist for personalized dosing.
Adults:
Ferric Maltol capsule should be taken in oral route, preferably on an empty stomach, at least 1 hour before or 2 hours after meals. Do not open, break or chew Ferric Maltol capsule. The recommended dosage of Ferric Maltol is 30 mg twice daily. Treatment duration will depend on the severity of iron deficiency but generally at least 12 weeks of treatment is required. The treatment should be continued as long as necessary until ferritin levels are within the normal range.Use in children and adolescents: Safety and effectiveness of ferric maltol have not been established in pediatric patients.
Side Effects
The most common side effects are flatulence, diarrhea, constipation, feces discolored, abdominal pain, nausea and vomiting.
Cautions & Contraindications
Warnings & Precautions
Avoid use of Malifa in patients with an active inflammatory bowel disease (IBD) flare, as there is potential risk of increased inflammation in the gastrointestinal tract. Do not administer to patients with evidence of iron overload or patients receiving intravenous iron. Assess iron parameters prior to initiating Malifa and monitor iron parameters while on therapy. Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6 years of age. In case of accidental overdose, patient should be treated immediately.
Contraindications
Ferric maltol is contraindicated in patients with known hypersensitivity to ferric maltol or any other components of this product. It is also contraindicated in patients with a history of hemochromatosis and other iron overload syndromes and in patients receiving repeated blood transfusions.